Terbinafine Tablet
Product Images NDC 16714-795

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Terbinafine (NDC 16714-795). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (250 mg (100 Tablet Bottle))

Package Label-principal Display Panel (250 mg (100 Tablet Bottle))
Terbinafine Tablets, USP is a product of India containing 100 tablets, each with 250mg of Terbinafine. This medication is manufactured by Aurobindo Pharma Limited and should be stored at 20° to 25°C (68° to 77°F) or permitted to 15° fo 30°C (3° to 86°F) [see USP Controlled Room Temperature]. Patients should be given the medication guide provided separately by the pharmacist. Dosage information is provided in the packaging. The medication guide is available at norbstarmis.com/products or by calling 1-800-206-7821. Revised: 0972021.*
FDA Label Image

Chemical Structure (Terbinafine Str)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.